Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N R Srinivas

Showing results (51-60 of 144) with videos related to

Pageof 15
Sort By:
Biopharmaceutics & Drug Disposition|December 18, 2001
In vitro protein binding studies with BMS-204352: lack of protein binding displacement interaction in human serumR Krishna, M Yao, D Kaczor, et al.
International Journal of Systematic and Evolutionary Microbiology|December 15, 2010
Lutibaculum baratangense gen. nov., sp. nov., a novel proteobacterium isolated from a mud volcano, Andamans, IndiaAnil P Kumar, T N R Srinivas, S Madhu, et al.
Seminars in Oncology|December 1, 1996
A pharmacodynamic evaluation of hematologic toxicity observed with etoposide phosphate in the treatment of cancer patientsS Kaul, N R Srinivas, L N Igwemezie, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1987
Stereoselective disposition of methylphenidate in children with attention-deficit disorderN R Srinivas, D Quinn, J W Hubbard, et al.
Systematic and Applied Microbiology|December 10, 2013
Lunatimonas lonarensis gen. nov., sp. nov., a haloalkaline bacterium of the family Cyclobacteriaceae with nitrate reducing activityT N R Srinivas, S Aditya, V Bhumika, et al.
Clinical Pharmacology and Therapeutics|November 1, 1992
Enantioselective pharmacokinetics and pharmacodynamics of dl-threo-methylphenidate in children with attention deficit hyperactivity disorderN R Srinivas, J W Hubbard, D Quinn, et al.
Biomedical Chromatography : BMC|September 9, 1999
Sensitive triple-quadrupole mass spectrometric assay for the determination of BMS-181885, a 5-HT1 agonist, in human plasma following solid phase extractionS Y Chang, D Whigan, W C Shyu, et al.
Arzneimittel-Forschung|February 1, 2012
The observed correlation between in vivo clinical pharmacokinetic parameters and in vitro potency of VEGFR-2 inhibitors. Can this be used as a prospective guide for the development of novel compounds?B Benjamin, M Sahu, U Bhatnagar, et al.
Journal of Pharmaceutical Sciences|September 2, 1998
Absolute bioavailability and dose proportionality of BMS-181885, an antimigraine agent, following the administration of single intranasal doses to cynomolgus monkeysN R Srinivas, W C Shyu, C W Soong, et al.
Current Microbiology|June 14, 2011
Identification of fruity aroma-producing compounds from Chryseobacterium sp. isolated from the Western Ghats, IndiaP Anil Kumar, T N R Srinivas, A R Prasad, et al.
Pageof 15

Showing results (51-60 of 144) with videos related to

Sort By:
Pageof 15
Biopharmaceutics & Drug Disposition|December 18, 2001
In vitro protein binding studies with BMS-204352: lack of protein binding displacement interaction in human serumR Krishna, M Yao, D Kaczor, et al.
International Journal of Systematic and Evolutionary Microbiology|December 15, 2010
Lutibaculum baratangense gen. nov., sp. nov., a novel proteobacterium isolated from a mud volcano, Andamans, IndiaAnil P Kumar, T N R Srinivas, S Madhu, et al.
Seminars in Oncology|December 1, 1996
A pharmacodynamic evaluation of hematologic toxicity observed with etoposide phosphate in the treatment of cancer patientsS Kaul, N R Srinivas, L N Igwemezie, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1987
Stereoselective disposition of methylphenidate in children with attention-deficit disorderN R Srinivas, D Quinn, J W Hubbard, et al.
Systematic and Applied Microbiology|December 10, 2013
Lunatimonas lonarensis gen. nov., sp. nov., a haloalkaline bacterium of the family Cyclobacteriaceae with nitrate reducing activityT N R Srinivas, S Aditya, V Bhumika, et al.
Clinical Pharmacology and Therapeutics|November 1, 1992
Enantioselective pharmacokinetics and pharmacodynamics of dl-threo-methylphenidate in children with attention deficit hyperactivity disorderN R Srinivas, J W Hubbard, D Quinn, et al.
Biomedical Chromatography : BMC|September 9, 1999
Sensitive triple-quadrupole mass spectrometric assay for the determination of BMS-181885, a 5-HT1 agonist, in human plasma following solid phase extractionS Y Chang, D Whigan, W C Shyu, et al.
Arzneimittel-Forschung|February 1, 2012
The observed correlation between in vivo clinical pharmacokinetic parameters and in vitro potency of VEGFR-2 inhibitors. Can this be used as a prospective guide for the development of novel compounds?B Benjamin, M Sahu, U Bhatnagar, et al.
Journal of Pharmaceutical Sciences|September 2, 1998
Absolute bioavailability and dose proportionality of BMS-181885, an antimigraine agent, following the administration of single intranasal doses to cynomolgus monkeysN R Srinivas, W C Shyu, C W Soong, et al.
Current Microbiology|June 14, 2011
Identification of fruity aroma-producing compounds from Chryseobacterium sp. isolated from the Western Ghats, IndiaP Anil Kumar, T N R Srinivas, A R Prasad, et al.
Pageof 15